JP2004513059A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004513059A5 JP2004513059A5 JP2000590684A JP2000590684A JP2004513059A5 JP 2004513059 A5 JP2004513059 A5 JP 2004513059A5 JP 2000590684 A JP2000590684 A JP 2000590684A JP 2000590684 A JP2000590684 A JP 2000590684A JP 2004513059 A5 JP2004513059 A5 JP 2004513059A5
- Authority
- JP
- Japan
- Prior art keywords
- aceeed
- pantp
- represented
- peptide product
- following structure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- -1 acetyl-glutamyl-glutamyl-glutamyl-aspartyl Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 206010049444 fibromatosis Diseases 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000010388 wound contraction Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98204396 | 1998-12-24 | ||
| PCT/EP1999/009964 WO2000038733A1 (en) | 1998-12-24 | 1999-12-15 | Peptidic product, process and composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004513059A JP2004513059A (ja) | 2004-04-30 |
| JP2004513059A5 true JP2004513059A5 (cg-RX-API-DMAC10.html) | 2007-03-15 |
Family
ID=8234532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000590684A Pending JP2004513059A (ja) | 1998-12-24 | 1999-12-15 | ペプチド産物、方法及び組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6335320B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1140202A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2004513059A (cg-RX-API-DMAC10.html) |
| AU (1) | AU762006B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2000038733A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0306165D0 (en) * | 2003-03-18 | 2003-04-23 | Delta G Ltd | Medical treatment |
| US20060198800A1 (en) * | 2003-08-14 | 2006-09-07 | Natalie Dilallo | Skin care compositions including hexapeptide complexes and methods of their manufacture |
| WO2005016364A1 (en) * | 2003-08-14 | 2005-02-24 | Guthy-Renker Corporation | Skin care composition including hexapeptide complexes and methods of their manufacture |
| RU2255757C1 (ru) * | 2004-06-22 | 2005-07-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Пептидное соединение, восстанавливающее функцию органов дыхания |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL296382A1 (en) * | 1991-02-02 | 1993-11-02 | Nika Health Products Ltd Li Li | Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system |
| US5254342A (en) * | 1991-09-30 | 1993-10-19 | University Of Southern California | Compositions and methods for enhanced transepithelial and transendothelial transport or active agents |
| US5534496A (en) * | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
| EP0903408A3 (en) * | 1992-08-21 | 2005-11-02 | Biogen, Inc. | Tat-derived transport polypeptide |
| US5837533A (en) * | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| US5846743A (en) * | 1995-02-22 | 1998-12-08 | Brigham And Women's Hospital, Inc. | Polyphoshoinositide binding peptides for intracellular drug delivery |
| FR2739621B1 (fr) * | 1995-10-05 | 1997-12-05 | Centre Nat Rech Scient | Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives |
| DE69736351T4 (de) * | 1996-05-08 | 2009-07-23 | Cyclacel Ltd. | Methoden und mittel zur hemmung der cdk4-aktivität |
| US6551994B1 (en) * | 1997-04-10 | 2003-04-22 | Mcgill University | Compounds and methods for inhibiting the interaction between α-catenin and β-catenin |
| EP1005357A1 (en) * | 1997-04-14 | 2000-06-07 | The Regents Of The University Of California | Peptide antiestrogen compositions and methods for treating breast cancer |
| GB9718609D0 (en) * | 1997-09-02 | 1997-11-05 | Imp College Innovations Ltd | Fusion protein |
| GB9814527D0 (en) * | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
| JP2002535247A (ja) * | 1998-11-26 | 2002-10-22 | ペンタファルム アクチェンゲゼルシャフト | 輸送系複合体 |
-
1999
- 1999-12-15 EP EP99966970A patent/EP1140202A1/en not_active Withdrawn
- 1999-12-15 JP JP2000590684A patent/JP2004513059A/ja active Pending
- 1999-12-15 WO PCT/EP1999/009964 patent/WO2000038733A1/en not_active Ceased
- 1999-12-15 AU AU22838/00A patent/AU762006B2/en not_active Ceased
- 1999-12-20 US US09/466,772 patent/US6335320B1/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3846901B2 (ja) | 腸送達用経口投与組成物およびその使用方法 | |
| US5534496A (en) | Methods and compositions to enhance epithelial drug transport | |
| US6337319B1 (en) | μ-Selective opioid peptides | |
| EP0181001B1 (en) | Polypeptide, a process for preparing the same, a pharmaceutical composition containing said polypeptide as well as the use thereof | |
| US20030035829A1 (en) | Liposomal compositions for the delivery of nucleic acid catalysts | |
| KR950701937A (ko) | 글루카곤-유사 펩티드 및 인슐리노트로핀 유도체(glucagon-like peptide and insulinotropin derivatives) | |
| US5843995A (en) | Inhibition of HIV-1 replication using oligocarbamate derivatives | |
| NZ281742A (en) | Opioid peptides used in treating pain | |
| KR880002608B1 (ko) | 펩타이드 유도체의 제법 | |
| Tóth et al. | Novel lipoamino acid-and liposaccharide-based system for peptide delivery: application for oral administration of tumor-selective somatostatin analogues | |
| RU2002130203A (ru) | Пептидные конъюгаты для доставки лекарственного средства | |
| Jinsmaa et al. | Oral Bioavailability of a New Class of μ-Opioid Receptor Agonists Containing 3, 6-Bis [Dmt-NH (CH2) n]-2 (1 H)-pyrazinone with Central-Mediated Analgesia | |
| EP0317573B1 (en) | Antipyretic and anti-inflammatory peptides | |
| US5783179A (en) | C-reactive protein fragment with immunomodulatory activity | |
| JP2006515744A5 (cg-RX-API-DMAC10.html) | ||
| FR2741076B1 (fr) | Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant | |
| JP2000502089A (ja) | 成長ホルモンの放出を促進できるｄ―２―アルキルトリプトファンを含有するオリゴペプチド化合物 | |
| RU2004114865A (ru) | Композиция и способ лечения диабета | |
| Patel et al. | Peptide Targeting and Delivery across the Blood− Brain Barrier Utilizing Synthetic Triglyceride Esters: Design, Synthesis, and Bioactivity | |
| CA2255661A1 (en) | Antiangiogenic drug to treat cancer, arthritis and retinopathy | |
| IE49755B1 (en) | Peptides having thymopoietin-like activity,therapeutic compositions containing them,and process for their preparation | |
| TW474945B (en) | Peptide derivatives having analgesic activity and capable of orally admistration | |
| CA1125281A (en) | Psychopharmacological peptides | |
| Nakata et al. | Physical dependence of a dermorphin tetrapeptide analog,[D-Arg2, Sar4]-dermorphin (1–4) in the rat | |
| CA2317107C (en) | Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus |